Evicenter
MarkdownMedical informationP&T meetings
Vonaprument (ANX007)

Geographic atrophy secondary to age-related macular degeneration

Launch
Not announced
Last updated
167 sources

Product information and disease descriptionProduct descriptionProduct information

Special populations

5 evidence topics · 4 sources

Age of enrolled participants: ARCHER and ARCHER II
CharacteristicARCHER (N = 270)ARCHER II (N = 659)
Age, mean (SD)“80.0 (8.2)”“78.4 (8.0)”
Pediatric use, renal impairment, and hepatic impairment

No evidence found.